Advert - Bausch & Lomb
-
Date posted01 February 2016
-
SanctionAdvertisement,
-
Case number/s
For not being sufficiently clear about the licensed doses for Emerade (adrenaline auto-injector), for making other misleading and unsubstantiated claims and disguising the promotion of its medicine, Bausch & Lomb UK Limited was ruled in breach of the following clauses of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry.
Clause 7.2 - Making a misleading claim.
Clause 7.4 - Making an unsubstantiated claim.
Clause 7.10 - Failing to encourage the rational use of a medicine.
Clause 9.1 - Failing to maintain high standards.
Clause 12.1 - Disguising promotional materials.